What are your thoughts on This Artical..
Bioshares recommendation: Speculative Hold Class B Timing -
Company Biotron Code BIT CMP $0.088 Cap'n ($M) $20.1 Cash ($M) 30/9 $3.5 SI 1.0
• Biotron is developing BIT225 to treat HCV and HIV co-infection; it has a novel mechanism of action, targeting the p7 protein on the virus
• Phase IIa trial showed that BIT225 twice daily in combo with ribavarin and peg-interferon reduced virus to undetectable levels after 28 days
• BIT's rationale for developing BIT225 is that it can address drug resistance issues that could emerge with other classes of HCV drugs
• Recently Gilead Sciences' sofusbuvir with ribavirin was recommended for approval by the FDA, for treating HCV genotypes 2 and 3
• Sofusbuvir with pegylated interferon was also recommended for approval for treating HCV genotypes 1 and 4
• Sofusbuvir cuts duration of treatment from 24 to 12 weeks, and delivers up to a 90% cure rate
• Gilead has a pan-genotype and interferon and ribavarin free regime of sofusbuvir and GS-5816 moving into Phase II
• Johnson & Johnson's simeprevir with peg-interferon and ribavarin for genotype 1, was also recommended for approval
• BIT intends to commence a 12 week trial of BIT225 in genotypes 1 and 3 subjects later in 2013
Comment: The number of new and improved HCV drugs nearing FDA approval diminish the prospects for BIT225
Bioshares recommendation: Sell Timing
- Forums
- ASX - By Stock
- BIT
- artical in bio shares
BIT
biotron limited
Add to My Watchlist
0.00%
!
0.2¢

artical in bio shares
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.654M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
59 | 40450562 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 17976809 | 23 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
59 | 40450562 | 0.002 |
33 | 67641001 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 17976809 | 23 |
0.004 | 12820969 | 17 |
0.005 | 6690600 | 5 |
0.006 | 1200000 | 2 |
0.007 | 484188 | 1 |
Last trade - 16.21pm 02/07/2025 (20 minute delay) ? |
Featured News
BIT (ASX) Chart |
Day chart unavailable
The Watchlist
RAC
RACE ONCOLOGY LTD
Dr Pete Smith, Executive Chairman
Dr Pete Smith
Executive Chairman
SPONSORED BY The Market Online